National Bank of Canada FI Has $3.43 Million Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

National Bank of Canada FI trimmed its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 25.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 383,216 shares of the pharmacy operator’s stock after selling 131,550 shares during the period. National Bank of Canada FI’s holdings in Walgreens Boots Alliance were worth $3,434,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in WBA. Iron Horse Wealth Management LLC boosted its position in shares of Walgreens Boots Alliance by 162.5% during the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 1,300 shares during the last quarter. Blue Trust Inc. increased its position in Walgreens Boots Alliance by 87.0% in the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 1,081 shares during the last quarter. Continuum Advisory LLC increased its holdings in Walgreens Boots Alliance by 71.2% in the 2nd quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock worth $30,000 after acquiring an additional 1,020 shares during the last quarter. Sentry Investment Management LLC bought a new stake in shares of Walgreens Boots Alliance in the third quarter valued at approximately $30,000. Finally, Eastern Bank bought a new stake in Walgreens Boots Alliance during the 3rd quarter valued at $33,000. 58.59% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. UBS Group lifted their price target on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research report on Thursday, October 17th. Truist Financial reduced their target price on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a report on Monday, October 7th. Royal Bank of Canada decreased their price target on Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating on the stock in a research report on Wednesday, December 4th. Bank of America cut their price objective on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research report on Wednesday, September 4th. Finally, Morgan Stanley decreased their target price on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a report on Friday, October 11th. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $12.58.

Walgreens Boots Alliance Stock Up 6.8 %

Shares of Walgreens Boots Alliance stock opened at $10.39 on Friday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $27.05. The company’s 50 day moving average price is $9.27 and its 200-day moving average price is $10.75. The stock has a market capitalization of $8.98 billion, a price-to-earnings ratio of -1.04, a P/E/G ratio of 1.29 and a beta of 0.66.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. The business had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The company’s revenue was up 5.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.67 EPS. Equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, December 12th. Shareholders of record on Monday, November 18th were issued a $0.25 dividend. The ex-dividend date was Monday, November 18th. This represents a $1.00 annualized dividend and a yield of 9.62%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -9.99%.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.